Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
LivaNova plc

Start price
Target price
Perf. (%)
€51.00
27.03.24
€69.29
27.03.25
-3.14%
17.04.24

Mizuho 
27.03.24 50%
buy
LivaNova plc

Start price
Target price
Perf. (%)
€51.00
20.03.24
-
20.03.25
-3.14%
17.04.24

Needham & Company LLC 
20.03.24 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€38.80
04.03.24
-
04.03.25
-4.64%
08:39

Guggenheim 
04.03.24 50%
buy
LivaNova plc

Start price
Target price
Perf. (%)
€52.00
21.02.24
€66.59
21.02.25
-5.00%
17.04.24

Needham & Company LLC 
21.02.24 50%
buy
LivaNova plc

Start price
Target price
Perf. (%)
€48.00
20.02.24
€64.66
20.02.25
2.92%
17.04.24

Mizuho 
20.02.24 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€38.80
13.02.24
-
13.02.25
-3.67%
08:39

Citigroup Inc. 
13.02.24 50%
buy
STERIS plc

Start price
Target price
Perf. (%)
-
09.02.24
€231.65
09.02.25
-
-

Stephens 
09.02.24 50%
buy
STERIS plc

Start price
Target price
Perf. (%)
-
06.02.24
€235.72
06.02.25
-
-

KeyCorp 
06.02.24 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
-5.10%
09:31

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€14.10
04.02.24
€22.00
31.03.26
-20.57%
16.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Amarin Corp. ADR

Start price
Target price
Perf. (%)
€0.77
21.12.23
-
21.12.24
12.34%
17.04.24

Cantor Fitzgerald 
21.12.23 50%
buy
CVS Group plc

Start price
Target price
Perf. (%)
€19.10
20.12.23
€23.00
01.04.25
-44.50%
17.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
tbackenh 
20.12.23 80%
sell
Amarin Corp. ADR

Start price
Target price
Perf. (%)
€0.72
20.11.23
-
20.11.24
20.14%
17.04.24

JPMorgan Chase & Co. 
20.11.23 50%
buy
LivaNova plc

Start price
Target price
Perf. (%)
€42.60
17.11.23
€57.02
17.11.24
14.55%
17.04.24

Needham & Company LLC 
17.11.23 50%
buy
Smith & Nephew plc ADR

Start price
Target price
Perf. (%)
€22.40
03.11.23
-
03.11.24
3.83%
17.04.24

JPMorgan Chase & Co. 
03.11.23 50%
buy
LivaNova plc

Start price
Target price
Perf. (%)
€45.40
23.10.23
€58.42
23.10.24
7.49%
17.04.24

Needham & Company LLC 
23.10.23 50%
buy
STERIS plc

Start price
Target price
Perf. (%)
-
25.09.23
€236.13
25.09.24
-
-

Stephens 
25.09.23 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€32.60
02.09.23
-
02.09.24
15.61%
08:39

StockNews.com 
02.09.23 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.00
31.08.23
-
31.08.24
7.01%
09:30

Finanzoo 
31.08.23 50%
buy
STERIS plc

Start price
Target price
Perf. (%)
-
03.08.23
€235.81
03.08.24
-
-

KeyCorp 
03.08.23 50%
sell
Amarin Corp. ADR

Start price
Target price
Perf. (%)
€1.00
20.07.23
€0.89
20.07.24
-13.50%
17.04.24

The Goldman Sachs Group, Inc. 
20.07.23 50%
buy
Smith & Nephew plc ADR

Start price
Target price
Perf. (%)
€27.00
07.07.23
-
07.07.24
-12.85%
17.04.24

StockNews.com 
07.07.23 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€31.40
22.06.23
€35.00
22.06.24
20.45%
08:39

Could be worthwhile Investment >10% per year
melinda 
22.06.23 10%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€124.30
11.11.22
€165.00
08.09.26
7.64%
09:39

ValueFreak 
11.11.22 50%